These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31444048)

  • 1. Female dominant association of sarcopenia and physical frailty in mild cognitive impairment and Alzheimer's disease.
    Ohta Y; Nomura E; Hatanaka N; Osakada Y; Matsumoto N; Sasaki R; Tsunoda K; Takemoto M; Tadokoro K; Hishikawa N; Wakutani Y; Yamashita T; Sato K; Omote Y; Abe K
    J Clin Neurosci; 2019 Dec; 70():96-101. PubMed ID: 31444048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relations of neuropsychiatric symptoms with disease stage, sex, and daily function in mild cognitive impairment and dementia due to Alzheimer's disease: A cross-sectional study.
    Zhang W; Wang X; Lü Y; Yu W
    J Psychosom Res; 2022 Oct; 161():110994. PubMed ID: 35939891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical associations of anosognosia in mild cognitive impairment and Alzheimer's disease.
    Mak E; Chin R; Ng LT; Yeo D; Hameed S
    Int J Geriatr Psychiatry; 2015 Dec; 30(12):1207-14. PubMed ID: 25754519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia Is Associated with Cognitive Impairment Mainly Due to Slow Gait Speed: Results from the Korean Frailty and Aging Cohort Study (KFACS).
    Kim M; Won CW
    Int J Environ Res Public Health; 2019 Apr; 16(9):. PubMed ID: 31035553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Stogmann E; Moser D; Klug S; Gleiss A; Auff E; Dal-Bianco P; Pusswald G; Lehrner J
    J Alzheimers Dis; 2016; 49(4):1043-50. PubMed ID: 26577522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis on the interrelationship between sarcopenia and mild cognitive impairment, Alzheimer's disease and other forms of dementia.
    Amini N; Ibn Hach M; Lapauw L; Dupont J; Vercauteren L; Verschueren S; Tournoy J; Gielen E
    J Cachexia Sarcopenia Muscle; 2024 Aug; 15(4):1240-1253. PubMed ID: 38715252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computerized touch-panel screening tests for detecting mild cognitive impairment and Alzheimer's disease.
    Fukui Y; Yamashita T; Hishikawa N; Kurata T; Sato K; Omote Y; Kono S; Yunoki T; Kawahara Y; Hatanaka N; Tokuchi R; Deguchi K; Abe K
    Intern Med; 2015; 54(8):895-902. PubMed ID: 25876569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of Frailty with Neuropsychiatric Symptoms of Alzheimer's Disease: A Longitudinal Study.
    Chi HC; Ma LZ; Wang ZB; Sheng ZH; Liu JY; Mi YC; Fu Y; Huang YM; Han SL; Gao PY; ; Tan L; Yu JT
    J Alzheimers Dis; 2024; 98(2):629-642. PubMed ID: 38427482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Case for Stage-Specific Frailty Interventions Spanning Community Aging to Cognitive Impairment.
    Chong MS; Tay L; Ismail NH; Tan CH; Yew S; Yeo A; Ye R; Leung B; Ding YY
    J Am Med Dir Assoc; 2015 Nov; 16(11):1003.e13-9. PubMed ID: 26543008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and psychological symptoms and cognitive decline in patients with amnestic MCI and mild AD: a two-year follow-up study.
    Pocnet C; Antonietti JP; Donati A; Popp J; Rossier J; von Gunten A
    Int Psychogeriatr; 2015 Aug; 27(8):1379-89. PubMed ID: 25592615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging biomarkers and screening for cognitive frailty.
    Ruan Q; D'Onofrio G; Sancarlo D; Greco A; Lozupone M; Seripa D; Panza F; Yu Z
    Aging Clin Exp Res; 2017 Dec; 29(6):1075-1086. PubMed ID: 28260159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral syndromes in mild cognitive impairment and Alzheimer's disease.
    Van der Mussele S; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2014; 38(2):319-29. PubMed ID: 23963290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and associated factors of sarcopenia in elderly subjects with amnestic mild cognitive impairment or Alzheimer disease.
    Sugimoto T; Ono R; Murata S; Saji N; Matsui Y; Niida S; Toba K; Sakurai T
    Curr Alzheimer Res; 2016; 13(6):718-26. PubMed ID: 26863996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia.
    Van der Mussele S; Le Bastard N; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Aging Ment Health; 2015; 19(3):247-57. PubMed ID: 24962058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory-cognitive index distinguishes involvement of frontal lobe shrinkage, as in sarcopenia from shrinkage of medial temporal areas, and global brain, as in Kihon Checklist frailty/dependence, in older adults with progression of normal cognition to Alzheimer's disease.
    Iritani O; Okuno T; Miwa T; Makizako H; Okutani F; Kashibayashi T; Suzuki K; Hara H; Mori E; Omoto S; Suzuki H; Shibata M; Adachi H; Kondo K; Umeda-Kameyama Y; Kodera K; Morimoto S
    Geriatr Gerontol Int; 2021 Mar; 21(3):291-298. PubMed ID: 33465821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective longitudinal study of frailty transitions in a community-dwelling cohort of older adults with cognitive impairment.
    Chong MS; Tay L; Chan M; Lim WS; Ye R; Tan EK; Ding YY
    BMC Geriatr; 2015 Dec; 15():175. PubMed ID: 26715536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.
    Guercio BJ; Donovan NJ; Munro CE; Aghjayan SL; Wigman SE; Locascio JJ; Amariglio RE; Rentz DM; Johnson KA; Sperling RA; Marshall GA
    J Alzheimers Dis; 2015; 47(2):421-32. PubMed ID: 26401564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anosognosia and neuropsychiatric symptoms and disorders in mild Alzheimer disease and mild cognitive impairment.
    Spalletta G; Girardi P; Caltagirone C; Orfei MD
    J Alzheimers Dis; 2012; 29(4):761-72. PubMed ID: 22349686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects.
    Richard E; Schmand B; Eikelenboom P; Yang SC; Ligthart SA; Moll van Charante EP; van Gool WA;
    Dement Geriatr Cogn Disord; 2012; 33(2-3):204-9. PubMed ID: 22722671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motivational processes in mild cognitive impairment and Alzheimer's disease: results from the Motivational Reserve in Alzheimer's (MoReA) study.
    Forstmeier S; Maercker A
    BMC Psychiatry; 2015 Nov; 15():293. PubMed ID: 26578083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.